These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21273056)

  • 21. [Relation of micro-RNA and carcinogenesis].
    Fan B; Zhang L; Ma C
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):401-4. PubMed ID: 22967438
    [No Abstract]   [Full Text] [Related]  

  • 22. p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics.
    Halaby MJ; Yang DQ
    Gene; 2007 Jun; 395(1-2):1-7. PubMed ID: 17395405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer biology: signatures guide drug choice.
    Downward J
    Nature; 2006 Jan; 439(7074):274-5. PubMed ID: 16421553
    [No Abstract]   [Full Text] [Related]  

  • 24. Beyond cancer genomics: after the end of the beginning.
    Venkitaraman AR
    Curr Opin Genet Dev; 2012 Feb; 22(1):1-2. PubMed ID: 22402446
    [No Abstract]   [Full Text] [Related]  

  • 25. [Molecular basis of oncogenesis induced by human papilloma viruses].
    Korita PV; Trotsenko OE; Annenkov AIu; Filimonov VV
    Vopr Onkol; 2012; 58(5):598-605. PubMed ID: 23600275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic splice variant of KLF6 as a prognostic marker in cancers.
    Khan MS; Bawany FI; Naeem M
    J Pak Med Assoc; 2013 Sep; 63(9):1215. PubMed ID: 24601213
    [No Abstract]   [Full Text] [Related]  

  • 27. Excavating relics of DNA methylation changes during the development of neoplasia.
    Hsiao SH; Huang TH; Leu YW
    Semin Cancer Biol; 2009 Jun; 19(3):198-208. PubMed ID: 19429484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-protein interactions for cancer therapy.
    Harris CC
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1659-60. PubMed ID: 16452164
    [No Abstract]   [Full Text] [Related]  

  • 29. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V; Gehrau RC; Bocco JL
    IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stochastic gene expression stabilization as a new therapeutic strategy for cancer.
    Capp JP
    Bioessays; 2012 Mar; 34(3):170-3. PubMed ID: 22231918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Normal' genes key to cancer growth.
    Check Hayden E
    Nature; 2008 Feb; 451(7179):615. PubMed ID: 18256629
    [No Abstract]   [Full Text] [Related]  

  • 32. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytically inactive telomerase in oncogenesis.
    Tergaonkar V
    Oncotarget; 2015 Jun; 6(17):14725-6. PubMed ID: 26142702
    [No Abstract]   [Full Text] [Related]  

  • 34. New insights emerging about mRNAs roles in cancer.
    Fillon M
    J Natl Cancer Inst; 2012 Jul; 104(13):972-3. PubMed ID: 22745471
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.
    Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):167-70. PubMed ID: 9593058
    [No Abstract]   [Full Text] [Related]  

  • 37. Curing "incurable" cancer.
    Watson JD
    Cancer Discov; 2011 Nov; 1(6):477-80. PubMed ID: 22586652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The alternative splicing side of cancer.
    Biamonti G; Catillo M; Pignataro D; Montecucco A; Ghigna C
    Semin Cell Dev Biol; 2014 Aug; 32():30-6. PubMed ID: 24657195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unraveling signalling cascades for the Snail family of transcription factors.
    De Craene B; van Roy F; Berx G
    Cell Signal; 2005 May; 17(5):535-47. PubMed ID: 15683729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial overview: cancer: from target discovery to targeted therapy: the risky business of target validation.
    Cruzalegui F
    Curr Opin Pharmacol; 2014 Aug; 17():iv-vi. PubMed ID: 25220882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.